Global, regional, and national burden of neurological disorders during 19902015: a systematic analysis for the Global Burden of Disease Study 2015
Patient-specific compounding under section 503A continues for cases with documented medical necessity (allergy to brand inactive ingredients, dose customization needs, etc.)
He has received educational and research grants from GE Healthcare, Novo Nordisk, Piramal Life Science/Life Molecular Imaging, Avid Radiopharmaceuticals, and Eli Lilly
The researchers discovered that both patient cohorts exhibited significant signs of elevated oxidative stress and consequent mitochondrial damage
Lets shatter limits together
The standard approach uses 2 ml of bacteriostatic water per vial, though different vial sizes may require adjustment